Opko Health Inc. (NASDAQ:OPK) is moving higher in Friday’s trading session.
As of 11:44, OPK stock fell 3.15% to $3.765. The stock has traded 1.08 million shares, compared to its average volume of 5.33 million shares. After opening at $3.71, the stock has moved within a wide range of $3.6950 – 3.8100.
OPK Releases News Today
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
- OPK announced a transfer of the licensed rights to RAYALDEE® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).
- On May 17, 2021, JT notified OPKO of its decision to terminate the exclusive agreement with OPKO’s subsidiary, EirGen Pharma, Ltd., for the development and commercialization of RAYALDEE® in Japan based on a comprehensive review of its development pipeline.
- Concurrently with the termination of JT’s rights, EirGen and VFMCRP have agreed to transfer the rights to RAYALDEE® in Japan to VFMCRP by including Japan into the existing exclusive agreement between the two companies, executed on May 9, 2016, for the development and commercialization of RAYALDEE® in Europe and certain other international markets for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) and vitamin D insufficiency.
|SHARES OUTSTANDING||670.16 M|
|SHARE FLOAT (%)||403.42 M (60.20%)|
|% HELD BY INSTITUTIONS||30.06|
Recent Stock Performance
|+/- EMA(20)||3.79 (-0.79%)|
|+/- SMA(50)||4.16 (-9.62%)|
|+/- SMA(200)||4.26 (-11.74%)|
|CCI20||-35.3615||Neutral||Chaikin Money Flow||-0.2941||Sell|
|MACD||-0.2031||Sell||Money Flow Index||33.4371||Buy|
|STOCH (14,3)||38.8235||Buy||STOCH RSI||0.9048||OverBought|